Early phase clinical trials extension to guidelines for the content of statistical analysis plans
Victoria Homer(Cancer Research UK Clinical Trials Unit), Piers Gaunt(Cancer Research UK Clinical Trials Unit), Christopher J. Weir(University of Edinburgh), Emily Robinson(Royal Marsden NHS Foundation Trust), Deborah Stocken(Cancer Research UK Clinical Trials Unit), Christina Yap(Institute of Cancer Research), Ly‐Mee Yu(Dartmouth–Hitchcock Medical Center), John Kirkpatrick(Roche (United Kingdom)), Simon Bond(Cambridge University Hospitals NHS Foundation Trust), Jane Holmes(University of Manchester), Matthew J. Schipper(EP Analytics (United States)), Khadija Rantell, Thomas J. Prior(Janssen (United States)), Sarah Brown(University of Leeds), Katrina Walker(University of Leeds), Samantha Hinsley(University of Leeds), Carrol Gamble(University of Liverpool), Alun Bedding(Roche (United Kingdom)), Graham Wheeler(Imperial College London)
Cited by 67
Related Papers
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k